Daniel Öhlund
@danielohlund.bsky.social
Associate professor in oncology at Umeå Univerity. Oncologist and pancreatic cancer researcher.
Lab website: https://www.umu.se/en/research/groups/ohlund-laboratory/
Lab website: https://www.umu.se/en/research/groups/ohlund-laboratory/
Happy to share that our project on the role of galectins in immune evasion has been awarded 6 MSEK in funding from the ErlingPersson Foundation. Grateful to the entire lab team and to the foundation for their support!
October 10, 2025 at 3:32 PM
Happy to share that our project on the role of galectins in immune evasion has been awarded 6 MSEK in funding from the ErlingPersson Foundation. Grateful to the entire lab team and to the foundation for their support!
Back home from the Swedish Cancer Research Meeting in Malmö. Great meeting! Our lab represented by Parniyan och Cedric! Good job!
May 26, 2025 at 6:59 AM
Back home from the Swedish Cancer Research Meeting in Malmö. Great meeting! Our lab represented by Parniyan och Cedric! Good job!
Reposted by Daniel Öhlund
🔦 #PANCAIDPartnerSpotlight: @umeauniversitet.bsky.social 🇸🇪
With unique prediagnostic & diagnostic biobank samples & translational research, Umeå contributes to PANCAID:
📦 WP1: Biomarkers + biobanking
🧭 WP5: Ethical insight from clinical care
@malinasund.bsky.social @danielohlund.bsky.social
With unique prediagnostic & diagnostic biobank samples & translational research, Umeå contributes to PANCAID:
📦 WP1: Biomarkers + biobanking
🧭 WP5: Ethical insight from clinical care
@malinasund.bsky.social @danielohlund.bsky.social
May 5, 2025 at 11:44 AM
🔦 #PANCAIDPartnerSpotlight: @umeauniversitet.bsky.social 🇸🇪
With unique prediagnostic & diagnostic biobank samples & translational research, Umeå contributes to PANCAID:
📦 WP1: Biomarkers + biobanking
🧭 WP5: Ethical insight from clinical care
@malinasund.bsky.social @danielohlund.bsky.social
With unique prediagnostic & diagnostic biobank samples & translational research, Umeå contributes to PANCAID:
📦 WP1: Biomarkers + biobanking
🧭 WP5: Ethical insight from clinical care
@malinasund.bsky.social @danielohlund.bsky.social
New paper published from our lab! Characterization of a new interferon-response CAFs with tumor-restraining properties.
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...
Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties
Abstract. Within the stroma of pancreatic ductal adenocarcinoma (PDAC), mesenchymal cells differentiate into cancer-associated fibroblast (CAF) subtypes that differentially mediate disease progression...
aacrjournals.org
April 11, 2025 at 6:08 PM
New paper published from our lab! Characterization of a new interferon-response CAFs with tumor-restraining properties.
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...